Back

NI956/QGC006, a potent orally active, brain-penetrating aminopeptidase A inhibitor prodrug for treating hypertension.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Heart values Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mathilde Keck

College de France INSERM U1050 Quantum Genomics, Paris (France)

11 More presentations in this session

Presentation thumbnail
Changes of TRPV4-BKCa complex in rat mesenteric artery in aging and hypertension
Professor Y. Yang (Luzhou, CN)
Presentation thumbnail
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
Professor M. Soares Sturzeneker (Ponta Grossa, BR)
Abstract Slides
Presentation thumbnail
Transforming growth factor-beta and arrhythmias in mitral valve prolapse patients
Professor E. Malev (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Notch-dependent endothelial dysfunction in patients with aortic valve calcification
Doctor A. Kostina (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
The number of lipoprotein(a) kringle IV-type 2 repeats is associated with the osteogenic profile of aortic valvular interstitial cells induced by plasma from patients with calcific aortic stenosis
Doctor D. Arangalage (Lausanne, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Heart values

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources